A New Monitoring Protocol for Clozapine-Induced Myocarditis Based on an Analysis of 75 Cases and 94 Controls

Kathlyn J. Ronaldson, Paul B. Fitzgerald, Andrew J. Taylor, Duncan J. Topliss, John J. McNeil

Australian & New Zealand Journal of Psychiatry · 2011 · 228 citations · 9 references

Abstract

This protocol recommends active monitoring for 4 weeks, relying predominantly on troponin and C-reactive protein results. It encourages continuation of clozapine in the presence of mild illness, but defines a threshold for cessation.

References

9